| |
| |
|
| Insider
Information: |
Riker Lauren Bullaro |
| Relationship: |
Senior Vice President,... |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,528 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$593,162 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,528 |
|
|
| Total
Value |
$593,162 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.2
|
| Percentage
Gain/Loss : |
0.0%
|
 133.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Senior Vice President,... |
2024-01-02 |
22,528 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Executive Director, Accounting |
• – – |
2012-03-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Executive Director, Accounting |
• – – |
2013-03-14 |
4 |
OE |
$10.34 |
$103,400 |
D/D |
10,000 |
12,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Executive Director, Accounting |
• – – |
2013-03-14 |
4 |
S |
$30.00 |
$300,000 |
D/D |
(10,000) |
2,000 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Executive Director, Finance |
• – – |
2015-03-16 |
4 |
OE |
$10.34 |
$51,700 |
D/D |
5,000 |
7,230 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Executive Director, Finance |
• – – |
2015-03-16 |
4 |
S |
$95.34 |
$476,700 |
D/D |
(5,000) |
2,230 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
5,980 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2016-06-06 |
4 |
S |
$47.20 |
$15,151 |
D/D |
(321) |
5,945 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2016-06-07 |
4 |
S |
$47.90 |
$29,555 |
D/D |
(617) |
5,328 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
8,453 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2017-06-05 |
4 |
S |
$43.32 |
$26,036 |
D/D |
(601) |
8,182 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2017-06-07 |
4 |
S |
$44.37 |
$49,650 |
D/D |
(1,119) |
7,063 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
10,063 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2017-12-15 |
4 |
S |
$43.70 |
$14,858 |
D/D |
(340) |
10,442 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-06-04 |
4 |
S |
$33.02 |
$26,449 |
D/D |
(801) |
9,641 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
12,141 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-08-22 |
4 |
S |
$44.48 |
$74,148 |
D/D |
(1,667) |
10,474 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-09-24 |
4 |
OE |
$10.34 |
$10,340 |
D/D |
1,000 |
11,474 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-09-24 |
4 |
AS |
$50.70 |
$50,700 |
D/D |
(1,000) |
10,474 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-11-02 |
4 |
AS |
$54.35 |
$54,350 |
D/D |
(1,000) |
10,474 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2018-11-02 |
4 |
OE |
$10.34 |
$10,340 |
D/D |
1,000 |
11,474 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-06-04 |
4 |
S |
$42.91 |
$41,494 |
D/D |
(967) |
10,268 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
12,168 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-06-10 |
4 |
S |
$44.28 |
$94,139 |
D/D |
(2,126) |
10,042 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-11-11 |
4 |
OE |
$10.34 |
$51,785 |
D/D |
5,000 |
15,640 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-11-11 |
4 |
S |
$43.59 |
$217,950 |
D/D |
(5,000) |
10,640 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
